K279-0892 Screening compound: ETHYL 2-[(2-OXO-3-{3-OXO-3-[(2-THIENYLMETHYL)AMINO]PROPYL}-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]ACETATE

K279-0892 Screening compound: ETHYL 2-[(2-OXO-3-{3-OXO-3-[(2-THIENYLMETHYL)AMINO]PROPYL}-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]ACETATE
K279-0892 Screening compound: ETHYL 2-[(2-OXO-3-{3-OXO-3-[(2-THIENYLMETHYL)AMINO]PROPYL}-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]ACETATE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-0892
ETHYL 2-[(2-OXO-3-{3-OXO-3-[(2-THIENYLMETHYL)AMINO]PROPYL}-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]ACETATE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-0892

Molecular Formula

C22H22N4O4S2 (C22 H22 N4 O4 S2)

Compound Name

ETHYL 2-[(2-OXO-3-{3-OXO-3-[(2-THIENYLMETHYL)AMINO]PROPYL}-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-5-YL)SULFANYL]ACETATE

IUPAC name

n/a

SMILES

CCOC(CSC(N1C2CCC(NCc3cccs3)=O)=Nc(cccc3)c3C1=NC2=O)=O

InChI

InChI=1S/C22H22N4O4S2/c1-2-30-19(28)13-32-22-24-16-8-4-3-7-15(16)20-25-21(29)17(26(20)22)9-10-18(27)23-12-14-6-5-11-31-14/h3-8,11,17H,2,9-10,12-13H2,1H3,(H,23,27)/t17-/m0/s1

InChI Key

QNNATUZRXDXTLQ-KRWDZBQOSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.57

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.254

Distribution Coefficient, logD

2.254

Water Solubility, LogSw

-2.76

Polar Surface Area

81.072

Acid Dissociation Constant (pKa)

10.29

Base Dissociation Constant (pKb)

3.90

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

31.80

K279-0892 in Drug Discovery

Included in Screening Libraries

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with K279-0892 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-0892?
Check Price and Availability of K279-0892, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-0892 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-0892
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-0892
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-0892 available by request